California sues 39 drug makers for inflated prices



LOS ANGELES (Reuters) - California's attorney general said on Thursday the state has filed a lawsuit accusing 39 pharmaceutical companies of bilking the state's Medicaid program by inflating drug prices.


Attorney General Bill Lockyer said he has added companies including Amgen Inc. and GlaxoSmithKline Plc to a previous complaint accusing Abbott Laboratories and Wyeth of hiding the true costs of their drugs so that payments from Medi-Cal -- California's health insurance program for the poor -- would be artificially inflated.